Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,801 | 11,323 | 15,112 | 17,474 | 18,122 |
| Receivables | 2,490 | 1,852 | 1,028 | 83 | 1,746 |
| TOTAL | $11,675 | $14,092 | $17,127 | $19,487 | $21,956 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $11,675 | $14,092 | $17,127 | $19,487 | $21,956 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,972 | 2,304 | 3,075 | 2,304 | 2,661 |
| TOTAL | $1,972 | $2,304 | $3,075 | $2,780 | $2,921 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 108 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,972 | $2,304 | $3,075 | $2,780 | $2,921 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,923 | 8,919 | 8,903 | 8,889 | 8,809 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -440,871 | -438,679 | -436,286 | -433,483 | -430,501 |
| TOTAL | $9,703 | $11,788 | $14,053 | $16,707 | $19,035 |
| Total Liabilities And Equity | $11,675 | $14,092 | $17,127 | $19,487 | $21,956 |